Search research articles
Contact Us
Filters
Showing results (161-170 of 170) with videos related to
Page
of 17
Sort By:
You have reached the last page of results.
This site can display upto 170 results.
The International Journal of Neuroscience
|
August 27, 2014
Cerebrovascular events in HIV-infected patients: an analysis of a cohort of 3203 HIV+ patients during the times of cART
Max Arentzen, Franziska Jubt, Stefan Evers, et al.
Journal of Neurology
|
June 2, 2017
HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment
Christian Eggers, Gabriele Arendt, Katrin Hahn, et al.
Medizinische Klinik (Munich, Germany : 1983)
|
March 15, 1994
[Mexiletine in treatment of painful diabetic neuropathy]
H Stracke, U Meyer, H Schumacher, et al.
Seizure
|
July 10, 2007
Frequency of seizures and epilepsy in neurological HIV-infected patients
C Kellinghaus, C Engbring, S Kovac, et al.
Annals of Clinical and Translational Neurology
|
September 25, 2015
Neurocognitive decline in HIV patients is associated with ongoing T-cell activation in the cerebrospinal fluid
Oliver M Grauer, Doris Reichelt, Ute Grüneberg, et al.
BMC Neurology
|
May 3, 2012
Early microstructural white matter changes in patients with HIV: a diffusion tensor imaging study
Bianca Stubbe-Drger, Michael Deppe, Siawoosh Mohammadi, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
December 3, 2016
The dopamine-related polymorphisms BDNF, COMT, DRD2, DRD3, and DRD4 are not linked with changes in CSF dopamine levels and frequency of HIV infection
Anne Horn, C Scheller, S du Plessis, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
September 24, 2013
Increases in CSF dopamine in HIV patients are due to the dopamine transporter 10/10-repeat allele which is more frequent in HIV-infected individuals
Anne Horn, Carsten Scheller, Stefan du Plessis, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
May 11, 2010
Increased dopaminergic neurotransmission in therapy-naïve asymptomatic HIV patients is not associated with adaptive changes at the dopaminergic synapses
C Scheller, G Arendt, T Nolting, et al.
Current Medical Research and Opinion
|
March 1, 2013
Mechanism- and experience-based strategies to optimize treatment response to the capsaicin 8% cutaneous patch in patients with localized neuropathic pain
R-D Treede, T Wagner, K-U Kern, et al.
Page
of 17
Search research articles
Search
Showing results (161-170 of 170) with videos related to
Sort By:
Page
of 17
You have reached the last page of results.
This site can display upto 170 results.
The International Journal of Neuroscience
|
August 27, 2014
Cerebrovascular events in HIV-infected patients: an analysis of a cohort of 3203 HIV+ patients during the times of cART
Max Arentzen, Franziska Jubt, Stefan Evers, et al.
Journal of Neurology
|
June 2, 2017
HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment
Christian Eggers, Gabriele Arendt, Katrin Hahn, et al.
Medizinische Klinik (Munich, Germany : 1983)
|
March 15, 1994
[Mexiletine in treatment of painful diabetic neuropathy]
H Stracke, U Meyer, H Schumacher, et al.
Seizure
|
July 10, 2007
Frequency of seizures and epilepsy in neurological HIV-infected patients
C Kellinghaus, C Engbring, S Kovac, et al.
Annals of Clinical and Translational Neurology
|
September 25, 2015
Neurocognitive decline in HIV patients is associated with ongoing T-cell activation in the cerebrospinal fluid
Oliver M Grauer, Doris Reichelt, Ute Grüneberg, et al.
BMC Neurology
|
May 3, 2012
Early microstructural white matter changes in patients with HIV: a diffusion tensor imaging study
Bianca Stubbe-Drger, Michael Deppe, Siawoosh Mohammadi, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
December 3, 2016
The dopamine-related polymorphisms BDNF, COMT, DRD2, DRD3, and DRD4 are not linked with changes in CSF dopamine levels and frequency of HIV infection
Anne Horn, C Scheller, S du Plessis, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
September 24, 2013
Increases in CSF dopamine in HIV patients are due to the dopamine transporter 10/10-repeat allele which is more frequent in HIV-infected individuals
Anne Horn, Carsten Scheller, Stefan du Plessis, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
May 11, 2010
Increased dopaminergic neurotransmission in therapy-naïve asymptomatic HIV patients is not associated with adaptive changes at the dopaminergic synapses
C Scheller, G Arendt, T Nolting, et al.
Current Medical Research and Opinion
|
March 1, 2013
Mechanism- and experience-based strategies to optimize treatment response to the capsaicin 8% cutaneous patch in patients with localized neuropathic pain
R-D Treede, T Wagner, K-U Kern, et al.
Page
of 17